CAS 1022899-36-0

Formel: C46H52BF2N11O3

InChl: InChI=1S/C46H52BF2N11O3/c1-32-28-33(2)58-40(32)29-36-15-14-35(59(36)47(58,48)49)16-19-41(61)51-20-23-56-26-24-55(25-27-56)21-7-11-42(62)57-22-6-8-37(30-57)60-46-43(45(50)52-31-53-46)44(54-60)34-12-17-39(18-13-34)63-38-9-4-3-5-10-38/h3-5,7,9-15,17-18,28-29,31,37H,6,8,16,19-27,30H2,1-2H3,(H,51,61)(H2,50,52,53)/b11-7+

InChI Key: YUGFMNZIROEBNV-YRNVUSSQSA-N

SMILES: [B-]1(N2C(=CC(=C2C=C3[N+]1=C(C=C3)CCC(=O)NCCN4CCN(CC4)C/C=C/C(=O)N5CCCC(C5)N6C7=NC=NC(=C7C(=N6)C8=CC=C(C=C8)OC9=CC=CC=C9)N)C)C)(F)F

PCI-33380

CAS: 1022899-36-0

Formel: C₄₆H₅₃BF₂N₁₁O₃

Reinheit: 98.0%

Molekulargewicht: 856.7927

Ref: IN-DA01EO8F

PCI-33380

CAS: 1022899-36-0

PCI-33380 is an irreversible inhibitor of Bruton's Tyrosine Kinase.

Formel: C₄₆H₅₂BF₂N₁₁O₃

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 855.785

Ref: TM-T16441

PCI-33380

CAS: 1022899-36-0

PCI-33380 is a small molecule inhibitor, which is a synthetic compound specifically designed to target and inhibit the mammalian target of rapamycin (mTOR) pathway. This pathway plays a critical role in cell growth, proliferation, and survival by sensing and integrating various environmental cues. Inhibition of mTOR using compounds like PCI-33380 disrupts these signaling cascades, affecting tumor progression and providing a potentially effective approach for cancer therapeutics.

Formel: C₄₆H₅₂BF₂N₁₁O₃

Reinheit: Min. 95%

Molekulargewicht: 855.78 g/mol

Ref: 3D-XQB89936